de Vries VA, et al. - Researchers studied the survival of 1,097 patients with a hematologic malignancy and multiple organ failure after admission to the ICU in this retrospective cohort study—part of the HEMA-ICU study group—with a follow-up of ≥ 1 year. To determine functional outcome, they used the World Health Organization (WHO) performance score measured 3 months after discharge from the ICU. A 38% 1-year survival rate was reported. There was an inverse link between multiple organ failure and long-term survival, and the strongest predictor of 1-year survival was an absence of respiratory failure. They reported survival rates of 27%, 22%, and 8% among patients with 2, 3, and 4 failing organs, respectively. A WHO performance score of 0–1 3 months after ICU discharge was noted in 39% of all surviving patients for whom WHO scores were available. There was no link between functional outcome and the number of failing organs. Overall, the authors advised that multiple organ failure should not be used as a criterion for excluding a patient with a hematologic malignancy from admission to the ICU.